Carl Goldfischer Insider Profile
4 Followers
Carl Goldfischer, Director at Damora Therapeutics, holds 0.00 shares in Epizyme (Ticker: EPZM), holds 29.02K shares in Damora Therapeutics (Ticker: DMRA), holds 703.38K shares in Enliven Therapeutics (Ticker: ELVN).
Carl Goldfischer's Trading History
| EPZMEpizyme | Aug 16, 2022 | ― | Uninformative Sell | ― | $0.00 | |
| DMRADamora Therapeutics | Nov 04, 2020 | Director | Uninformative Buy | ― | $626.81K | |
| ELVNEnliven Therapeutics | Mar 16, 2020 | Director | Uninformative Buy | ― | $34.32M | |
| ~RSLSReShape Lifesciences | May 26, 2017 | ― | Informative Buy | 22.64K | $662.30K | |
| CBAYCymaBay Therapeutics | Sep 11, 2015 | ― | Informative Sell | 128.15K | $0.00 | |
| PARDPoniard Pharmaceuticals | Jun 10, 2011 | Director | Uninformative Buy | ― | ― | |
| ~MAPPMap Pharmaceuticals | ― | ― | ― | ― |
You May Also Like
Carl Goldfischer insider profile FAQ
What is the percentage of profitable transactions made by Carl Goldfischer?
The percentage of profitable transactions made by Carl Goldfischer is 75%.
What is the average return per transaction made by Carl Goldfischer?
The average return per transaction made by Carl Goldfischer is 4.20%.
What stocks does Carl Goldfischer hold?
Carl Goldfischer holds: DMRA, EPZM, ELVN, ~RSLS, CBAY, ~MAPP, PARD stocks.
What was Carl Goldfischer's most profitable transaction?
Carl Goldfischer’s most profitable transaction was an Informative Sell of EPZM stock on August 25, 2014. The return on the trade was 52.50%.
What is Carl Goldfischer's role in Damora Therapeutics?
Carl Goldfischer's role in Damora Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
